The page below is a sample from the LabCE course The Toxicology Laboratory's Role in Pain Management. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about The Toxicology Laboratory's Role in Pain Management (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 97 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Cutoff Concentrations for DOA Screening Tests

Drug screens use cutoff concentrations to distinguish between negative and positive samples. For a qualitative test like a urine drug screen it is important to consider that some arbitrary threshold has to be met for the assay to be positive. The cutoff points for drugs of abuse on screening panels are usually determined by the immunoassay manufacturer. However, they can be adjusted by the laboratory, if the laboratory prefers a higher or lower cutoff.
Clinicians may over-interpret cutoffs and should be reminded that a negative result on a screening test does not necessarily mean that the drug is not present in the sample, only that it is less than the cutoff concentration established by the manufacturer or laboratory for that drug. For example, if a sample screens negative for oxycodone, there may be oxycodone present in the sample, but the concentration could be less than the laboratory's cutoff, eg, 100 ng/mL.
Cutoff concentrations should be posted with all laboratory screening results.
Below are some typical cutoff concentrations for DOA screens:

Typical Cutoff Concentration
500 ng/mL
Barbiturates200 ng/mL
50 ng/mL
300 ng/mL
100 ng/mL
300 ng/mL
300 ng/mL
200 ng/mL